On March 23,  JIC Leasing (Shanghai) successfully issued an ABS for epidemic prevention and control on the Shanghai Stock Exchange. The issuance scale of this ABS is 1.166 billion yuan, and the weighted average interest rate 3.76%. The issuance rates of A1, A2 and B are 3.4%, 3.9% and 4.99% respectively, lower than those of other companies with the same rating and from the same industry in the recent market. The subscription multiple is twofold and the ABS is widely recognized by the market.

18 assets in this ABS package are hospitals designated for treatment of COVID-19, designated nucleic acid testing institutions, designated fever clinics, and other institutions related to epidemic prevention and control. The funds raised will be used to support designated hospitals, enterprises related to epidemic prevention and control, or clients greatly affected by the epidemic.

A wholly-owned subsidiary of JIC Leasing, JIC Leasing (Shanghai) was established in the China (Shanghai) Pilot Free Trade Zone. Relying on the unique advantages of the Shanghai Free Trade Zone, JIC Leasing (Shanghai) focuses on strategic emerging areas such as healthcare and education. The successful issuance of the epidemic prevention and control ABS shows that  JIC Leasing (Shanghai) is active in providing financing services for the real economy as well as strongly supporting frontline anti-epidemic work.